Laurel Wealth Advisors (California)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,498
Closed -$285K 439
2018
Q3
$285K Buy
1,498
+39
+3% +$7.17K 0.07% 294
2018
Q2
$243K Sell
1,459
-31
-2% -$4.98K 0.06% 315
2018
Q1
$250K Buy
1,490
+152
+11% +$25.5K 0.08% 276
2017
Q4
$218K Buy
1,338
+58
+5% +$10.4K 0.06% 315
2017
Q3
$262K Buy
1,280
+11
+0.9% +$2.56K 0.09% 245
2017
Q2
$308K Sell
1,269
-144
-10% -$33.8K 0.11% 206
2017
Q1
$337K Sell
1,413
-216
-13% -$50.3K 0.13% 181
2016
Q4
$342K Buy
1,629
+411
+34% +$85.1K 0.15% 165
2016
Q3
$281K Buy
1,218
+113
+10% +$27.6K 0.13% 185
2016
Q2
$255K Sell
1,105
-2
-0.2% -$461 0.12% 199
2016
Q1
$297K Sell
1,107
-27
-2% -$7.73K 0.15% 171
2015
Q4
$354K Buy
+1,134
New +$338K 0.18% 151

Other funds holding AGN

Laurel Wealth Advisors (California)'s AGN Position: Q4 2018 in Review

Laurel Wealth Advisors (California) sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,498 shares — an estimated $285K sold.

Laurel Wealth Advisors (California) first reported a position in AGN in Q4 2015 and held it in 12 quarters. The position peaked at $354K in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Laurel Wealth Advisors (California) reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 1,498 Allergan plc shares in Q4 2018, an estimated $285K.
  • Laurel Wealth Advisors (California) first reported a position in Allergan plc in Q4 2015 and held it in 12 quarters.
  • Laurel Wealth Advisors (California)'s Allergan plc position peaked at $354K in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2018, filed 13 Feb 2019.